The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising

8 Jan 2007 07:00

Amphion Innovations PLC08 January 2007 Amphion Innovations plc Fundraising Monday 8 January 2007 - Amphion Innovations plc, the developer of life scienceand medical technology businesses, announces today that it successfully closed afundraising of £612,500 (before expenses) on 29th December 2006, the shares wereallotted and issued on 12 January, 2007. Under the terms of the placing, the Company has issued 2,450,000 new ordinaryshares at 25 pence per share ("the Placing Shares"). The net proceeds from the placing will be used to invest in new and identifiedopportunities. Application will be made for the Placing Shares to be admitted to trading onAIM. It is expected that admission will occur at 8am on Thursday 11th January2007. The Placing Shares will rank pari passu in all respects with the existingOrdinary Shares which are currently traded on AIM. Following admission thetotal number of shares in issue will be 100,100,224. As part of the Placing Richard Morgan, a director of Amphion, acquired 300,000Ordinary Shares in the Company at the placing price of 25p per Ordinary Share.Richard Morgan is now interested in 16,289,703 Ordinary Shares representingapproximately 16.274 per cent. of the total number of Ordinary Shares in issuefollowing the Placing. In addition, as part of the Placing, Amphion Capital Partners (a related entityand existing shareholder) acquired 1.025m Ordinary Shares in the Company and isnow interested in 8,025,000 Ordinary Shares representing 8.017 per cent. of thetotal number of Ordinary Shares in issue following the Placing. The shares areregistered in the name of Amphion Capital Partners. The partners in AmphionCapital Partners are Richard Morgan, Robert Bertoldi, Richard Mansell-Jones,Anthony Henfrey and Jim Macaleer, all of whom are directors of AmphionInnovations. Amphion Innovations Directors' interest in Amphion Capital Partners: R.James Macaleer 29.8%Richard Morgan 13.66%Robert Bertoldi 8.54%Richard Mansell-Jones 2.03%Anthony Henfrey 1.32% Total 55.35% For further information please contact: Amphion Innovations plcJosh Berkman, Media Relations +1 (646) 747 7158 Financial Dynamics +44 207 269 7169Ben AtwellJohn Gilbert About Amphion Innovations plc Amphion Innovations plc is listed on the AIM Exchange in London under the symbolAMP. Amphion's business is the formation, financing, management and developmentof life sciences and technology companies, primarily in the US and UK, workingin partnership with corporations, governments, universities and entrepreneursseeking to commercialize their intellectual property. On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.